IMMUNOVIA
Immunovia is a strategic center for translational cancer research in Lund, Sweden. Immunovia’s strategy is to decipher a large amount of information in the blood and translate it into clinically useful tools to diagnose complex diseases such as cancer and to do this earlier and more accurately than previously possible. Immunovia’s core technology platform, IMMray™, is based on antibody microarray analysis.
IMMUNOVIA
Industry:
Biotechnology Clinical Trials Health Diagnostics
Founded:
2007-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.immunovia.com
Total Employee:
11+
Status:
Active
Contact:
+46-46-275 60 00
Email Addresses:
[email protected]
Total Funding:
48.71 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:IMMNOV
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Immunovia
Key Employee Changes
Official Site Inspections
http://www.immunovia.com Semrush global rank: 2.1 M Semrush visits lastest month: 9.83 K
- Host name: rackfish-websrv02.ad.rackfish.net
- IP address: 194.169.225.96
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
Loading ... 